Article ; Online: Targeting the Annexin A1-FPR2/ALX pathway for host-directed therapy in dengue disease.
2022 Volume 11
Abstract: Host immune responses contribute to dengue's pathogenesis and severity, yet the possibility that failure in endogenous inflammation resolution pathways could characterise the disease has not been contemplated. The pro-resolving protein Annexin A1 (AnxA1) ...
Abstract | Host immune responses contribute to dengue's pathogenesis and severity, yet the possibility that failure in endogenous inflammation resolution pathways could characterise the disease has not been contemplated. The pro-resolving protein Annexin A1 (AnxA1) is known to counterbalance overexuberant inflammation and mast cell (MC) activation. We hypothesised that inadequate AnxA1 engagement underlies the cytokine storm and vascular pathologies associated with dengue disease. Levels of AnxA1 were examined in the plasma of dengue patients and infected mice. Immunocompetent, interferon (alpha and beta) receptor one knockout (KO), AnxA1 KO, and formyl peptide receptor 2 (FPR2) KO mice were infected with |
---|---|
MeSH term(s) | Animals ; Annexin A1/metabolism ; Dengue/drug therapy ; Humans ; Inflammation/pathology ; Mice ; Peptides/metabolism ; Receptors, Formyl Peptide/metabolism ; Receptors, Lipoxin/metabolism |
Chemical Substances | Annexin A1 ; FPR2 protein, human ; Peptides ; Receptors, Formyl Peptide ; Receptors, Lipoxin |
Language | English |
Publishing date | 2022-03-16 |
Publishing country | England |
Document type | Journal Article ; Research Support, Non-U.S. Gov't |
ZDB-ID | 2687154-3 |
ISSN | 2050-084X ; 2050-084X |
ISSN (online) | 2050-084X |
ISSN | 2050-084X |
DOI | 10.7554/eLife.73853 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.